H
Hector A. Cabrera-Fuentes
Researcher at National University of Singapore
Publications - 69
Citations - 2428
Hector A. Cabrera-Fuentes is an academic researcher from National University of Singapore. The author has contributed to research in topics: Myocardial infarction & Cardioprotection. The author has an hindex of 23, co-authored 67 publications receiving 1648 citations. Previous affiliations of Hector A. Cabrera-Fuentes include The Heart Research Institute & Kazan Federal University.
Papers
More filters
Journal ArticleDOI
Inflammation following acute myocardial infarction: Multiple players, dynamic roles, and novel therapeutic opportunities.
Sang Bing Ong,Sauri Hernández-Reséndiz,Gustavo E. Crespo-Avilan,Regina T. Mukhametshina,Xiu Yi Kwek,Hector A. Cabrera-Fuentes,Derek J. Hausenloy +6 more
TL;DR: An overview of the multiple players (and their dynamic roles) involved in the complex inflammatory response to AMI and subsequent LV remodeling is provided, and future opportunities for targeting inflammation as a therapeutic strategy for limiting MI size, preventing adverse left ventricular remodeling, and reducing heart failure in AMI patients are highlighted.
Journal ArticleDOI
Immune cells as targets for cardioprotection: new players and novel therapeutic opportunities
Ioanna Andreadou,Hector A. Cabrera-Fuentes,Yvan Devaux,Nikolaos G. Frangogiannis,Stefan Frantz,Tomasz J. Guzik,Elisa A. Liehn,Clarissa P.C. Gomes,Rainer Schulz,Derek J. Hausenloy +9 more
TL;DR: An overview of the immune cells involved in orchestrating the complex and dynamic inflammatory response to AMI are provided, including neutrophils, monocytes/macrophages, and emerging players such as dendritic cells, lymphocytes, pericardial lymphoid cells, endothelial cells, and cardiac fibroblasts.
Journal ArticleDOI
Mitochondrial fusion and fission proteins as novel therapeutic targets for treating cardiovascular disease.
TL;DR: The role of the mitochondrial fusion and fission proteins are reviewed as novel therapeutic targets for treating cardiovascular disease.
Journal ArticleDOI
Circulating blood cells and extracellular vesicles in acute cardioprotection
Sean M. Davidson,Ioanna Andreadou,Lucio Barile,Yochai Birnbaum,Hector A. Cabrera-Fuentes,Michael V. Cohen,James M. Downey,Henrique Girão,Pasquale Pagliaro,Claudia Penna,John Pernow,Klaus T. Preissner,Péter Ferdinandy +12 more
TL;DR: There is increasing evidence that non-cardiomyocyte resident cells in the heart as well as circulating cells and factors play important roles in this pathology, focussing on potential therapeutic targets relevant to IR injury.
Journal ArticleDOI
Innate immunity as a target for acute cardioprotection.
Coert J. Zuurbier,Antonio Abbate,Hector A. Cabrera-Fuentes,Michael V. Cohen,Massimo Collino,Dominique P.V. de Kleijn,James M. Downey,Pasquale Pagliaro,Klaus T. Preissner,Masafumi Takahashi,Sean M. Davidson +10 more
TL;DR: Evidence will be discussed that suggests agents targeting innate immunity may be a promising means of protecting the hearts of STEMI patients against acute IR injury and the dosing and timing of such agents should be carefully determined because innate immunity pathways may also be involved in cardioprotection.